USE OF BUPRENORPHINE IN PREGNANCY: PATIENT MANAGEMENT AND EFFECTS ON THE NEONATE
Saved in:
JOHNSON, R.E., ET AL., USE OF BUPRENORPHINE IN PREGNANCY: PATIENT MANAGEMENT AND EFFECTS ON THE NEONATE. DRUG AND ALCOHOL DEPENDENCE, Vol. 70, no. 2 SUPL. (2003), p. S87-S101.
Ref.
121195
Location:
SIIS R.854 Archivo
Palabras clave:
Antagonistas, Buprenorfina, Drogodependencias, Efectos, Embarazo, Fármacos, Feto, Heroína, Programas de desintoxicación, Programas de mantenimiento, Recién nacido
Antagonistas, Buprenorfina, Drogodependencias, Efectos, Embarazo, Fármacos, Feto, Heroína, Programas de desintoxicación, Programas de mantenimiento, Recién nacido
Similar Items: USE OF BUPRENORPHINE IN PREGNANCY: PATIENT MANAGEMENT AND EFFECTS ON THE NEONATE
- BUPRENORPHINE AND METHADONE TREATMENT OF OPIATE DEPENDENCE DURING PREGNANCY: COMPARISON OF FETAL GROWTH AND NEONATAL OUTCOMES IN TWO CONSECUTIVE CASE SERIES
- THE CLINICAL PHARMACOLOGY OF BUPRENORPHINE: EXTRAPOLATING FROM THE LABORATORY TO THE CLINIC
- BUPRENORPHINE: HOW TO USE IT RIGHT
- PHARMACOKINETICS OF THE COMBINATION TABLET OF BUPRENORPHINE AND NALOXONE
- CLINICAL AND PHARMACOLOGICAL EVALUATION OF BUPRENORPHINE AND NALOXONE COMBINATIONS: WHY THE 4:1 RATIO FOR TREATMENT?
- NEONATAL OUTCOME FOLLOWING BUPRENORPHINE MAINTENANCE DURING CONCEPTION AND THROUGHOUT PREGNANCY